Keywords
How to Cite
Abstract
The main ways of coronavirus penetration into the nervous system and the mechanisms of development of the main neurological complications of COVID‑19 are considered in the article. Preliminary results of the analysis of changes in the functional state of the central nervous system of 36 patients with dyscirculatory encephalopathy of atherosclerotic and hypertensive genesis 1-2 stages before and 3-4 months after COVID‑19 are presented. Reorganization of the bioelectrical activity of the brain, which is characterized by an increase in the general EEG structure of power in the range of slow rhythms against the background of a decrease in power in the range of cortical rhythms, as well as a tendency to a decrease in cerebral blood flow in individual vessels of the carotid and vertebro-basilar basins was established in patients after COVID‑19. This determines the feasibility of inclusion in a comprehensive system of post-COVID‑19 rehabilitation of medicines with multimodal vasoactive and metabolic action.
References
2. Гнездицкий В.В. Обратная задача ЭЭГ и клиническая электроэнцефалография. — М.: Медпресс-информ, 2004. — 626 с.
3. Преображенская И.С. Неврологические проявления COVID‑19 // Эффективная фармакотерапия. — 2020. — Т. 16. № 23. — С. 50-55.
DOI 10.33978/2307-3586-2020-16-23-50-55.
4. Baig A.M., Khaleeq A., Ali U., et al. Evidence of the COVID‑19 virus targeting the CNS: tissue distribution, hostvirus interaction, and proposed neurotropic mechanisms // ACS Chem. Neurosci. — 2020. — Vol. 11 (7). — P. 995-998.
5. Bolay H., Gül A., Baykan B. COVID‑19 is a Real Headache! // Headache. — 2020 Jul. — Vol. 60 (7). — P. 1415-1421. doi: 10.1111/head.13856. Epub 2020 May 27.
6. Bereczki D., Stang R., Böjti P., Kovács T. Neurological aspects of the COVID‑19 pandemic caused by the SARS-CoV‑2 coronavirus // Ideggyogy Sz. — 2020. PMID: 32579306 Review. Hungarian.
7. Chan J.F., Chan K.H., Choi G.K., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation // J. Infect Dis. — 2013. — Vol. 207 (11). — P. 1743-1752.
8. Chan, J.F. — W., Yuan, S., Kok, K. — H. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster // Lancet. — 2020. — Vol. 395. — P. 514-523.
9. Chen T., Wu D., Chen H., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [published correction appears in BMJ. 2020 Mar 31;368: m1295] // BMJ. — 2020. — Vol. 368: m1091.
10. Galanopoulou A.S., Ferastraoaru V., Correa D.J., et al. EEG findings in acutely ill patients investigated for SARS-CoV‑2/COVID‑19: A small case series
preliminary report // Epilepsia Open. — 2020. — Vol. 5. — P. 314.
11. Jacomy H., Fragoso G., Almazan G., et al. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice // Virology. — 2006. — Vol. 349 (2). — P. 335-346.
12. John Hopkins University (Coronavirus Resource Center). Euromonitor. BCG Analysis. 23 March 2020.
13. Junior I., Nascimento B., Cacic N. et al. Novel Coronavirus Infection (COVID‑19) in Humans: A Scoping Review and Meta-Analysis // J. Clin. Med. — 2020 Mar 30. — Vol. 9 (4). DOI: 10.3390/jcm9040941.
14. Kubota T., Gajera P.K., Kuroda N. Meta-analysis of EEG findings in patients with COVID‑19 // Epilepsy Behav. — 2021 Feb. — Vol. 115:107682. doi:
10.1016/j.yebeh.2020.107682. Epub 2020 Dec 4.
15. Le Guennec L., Devianne J., Jalin L., et al. Orbitofrontal involvement in a neuroCOVID‑19 patient // Epilepsia. — 2020.